4,4-Dichlorodiphenyl Sulfone (DCDPS) Market

4,4-Dichlorodiphenyl Sulfone (DCDPS) Market Outlook (2022 to 2032)

The global 4,4-dichlorodiphenyl sulfone market accounted for a valuation of US$ 402 million in 2021 and is estimated to project an upward growth trajectory and reach US$ 638 million by the end of 2032.

Demand for 4,4-dichlorodiphenyl sulfone (DCDPS) is predominantly increasing in the pharmaceutical and life sciences industry. It is the precursor for the development of equipment used in critical life science applications such as hemodialysis. Heavy investment to strengthen the medical infrastructure is the main driving factor for the growth of the DCDPS market.

Report Attributes	Details
4,4-Dichlorodiphenyl Sulfone Market Size (2021A)	US$ 402 Million
Estimated Market Value (2022E)	US$ 419 Million
Forecasted Market Value (2032F)	US$ 638 Million
Global Market Growth Rate (2022 to 2032)	4.2% CAGR
Americas Market Share (2021)	~15.6%
East Asia Market Growth Rate (2022 to 2032)	~3.9% CAGR
India Market Growth Rate (2022 to 2032)	~5% CAGR
Market Share of Top 5 Companies	~60%
Key Companies Profiled	Solvay S.A; Aarti Industries Limited; Atul Limited; Vertellus Holdings LLC; Hebei Xulong Chemical Co. Ltd.; Jiujiang Zhongxing Medicine Chemical Co. Ltd.; TCI Chemicals (India) Private Limited; Banchem Intermediates (India) Private

Market Overview: Historical (2017 to 2021) Vs. Forecast Timeframe (2022 to 2032)

The pharmaceutical industry is set to grow at a faster rate going forward owing to its unique role in developing new medicines and vaccines to improve the lives of patients worldwide. DCDPS is considered to be a very important component, especially for the development of polymers used in critical medical procedures.

Government initiatives for the production of pharma grade 4,4-dicholordiphenyl sulfone are an enticing opportunity for market players to enhance their production capacity as well as the quality of the substrate being produced.

In addition, demand for sulphone polymers is also surging from the aerospace and automotive industries. To comply with government rules, the transition of metals to plastics has been observed. This progression would also result in reduced CO2 emissions into the environment

• Short Term (2022 to 2025): Escalating demand for DCDPS from the healthcare industry is a major driving factor. Even in industrialized nations, the healthcare system has suffered a serious breakdown. To overcome this in the future, efforts from governments to strengthen the healthcare system are benefitting the DCDPS market.
• Medium Term (2025 to 2028): South Asia & Oceania are major consumers of 4,4-dichlorodiphenyl sulfone. Resurfacing leprosy patients in various regions coupled with patient density in the Asian region will increase the demand for DCDPS for the production of Dapsone.
• Long Term (2028 to 2032): Owing to increasing sales of electric/hybrid vehicles, the demand for engineered plastics is expected to increase along with the growing scope of new applications, resulting in the growing demand for DCDPS for the manufacturing of sulfone polymers.

The 4,4-dicholordiphenyl sulfone market witnessed a growth rate of 2.7% during the historical period (2017 to 2021) and is all set to inflate at 4.2% CAGR during the projected time of 2022 to 2032, reports Fact.MR, a market research and competitive intelligence service provider

Market evaluation of 4,4-dichlorodiphenyl sulfone based on application and region. Under the application segment, engineered plastics dominate the market with 75.2% share in 2022.

Factors Influencing 4,4-Dichlorodiphenyl Sulfone Market Growth

“E-Mobility Set to Propel DCDPS Production”

DCDPS is used to manufacture various high temperature-resistant engineered plastics such as PESU, PSU, PPSU, and other sulfone polymers used in the production of various components of e-motors, such as insulation coils, start & stop components in micro-hybrid vehicles, battery components, etc.

As a result, demand for engineered plastics is expected to increase along with the growing scope for new applications over the forecast period. This will result in an increase in the demand for DCDPS for the production of engineered plastics such as PSU, PESU, and PPSU.

Globally, increasing demand for electric vehicles to replace current fuel-powered vehicles will propel the utilization of sulfone polymers in the aforementioned applications. To cater to increasing electric vehicle demand, manufacturers specializing in automotive materials are highly inclined towards making sulfone polymers that are produced through DCDPS

“Movement of ‘Anti-Leprosy World 2020’ to Create Path for Growth of DCDPS”

4,4-dichlorodiphenyl sulfone is used for the production of an anti-leprosy drug called Dapsone. Dapsone plays a crucial role in treating leprosy, resulting in a decrease in the number of leprosy patients by 8,501 in 2018 as compared to the preceding year.

• The ‘Anti-Leprosy World 2020’ movement initiated by WHO presents an enormous opportunity for manufacturers to produce pharma grade 4,4-dchlorodiphenyl sulfone.

72% of leprosy cases are from South East Asia, coupled with the second-largest pharmaceutical industry, which is anticipated to increase the demand for DCDPS for manufacturing Dapsone. Investors are yet to realize this opportunity to leverage their cash flow for supplying 4,4-dichlorodiphenyl sulfone for expansion in the anti-leprosy drug market.

“Market Titans to Capitalize on Increasing Demand for Sulfone Polymers”

DCDPS is extensively used for manufacturing various sulfone polymers such as poly ether sulfone (PES), poly sulfone (PSU), poly phenylene sulfone (PPSU), and high-temperature and high-performance products in various end-use industries, such as the electrical industry.

PPSU is prominently utilized in aircraft interiors while other sulfone polymers such as PESU and PPSU applications are found in coatings, composite fuel systems, and others, providing an enormous opportunity for DCDPS manufacturers to leverage forward integration for the production of sulfone polymers.

Realizing this opportunity, titans such as Solvay and Atul Ltd. leveraged their DCDPS for the manufacturing of sulfone polymers (poly ether sulfone, poly sulfone, and poly phenylene sulfone) and DAPSONE (diaminodiphenyl sulfone) respectively, to cater to the increasing demand for sulfone polymers from various end-use industries.

“Lateral Integration by Key Players to Lead to DCDPS Deficit”

Over the forecast period, the world is set to face a DCDPS deficit owing to the forward integration of DCDPS products. Products generated using DCDPS as a starting material, such as sulfone polymers (poly ether sulfone, poly sulfone, and poly phenylene sulfone) will create high $ opportunity for companies over the period owing to the increase in the demand for sulfone polymers. Manufacturers are thus producing sulfone polymers and Dapsone to cater to a bundle of end-use industries and to maximize their profits.

On the other side of the coin, the adoption of lateral integration by DCDPS manufacturers has created a DCDPS deficit in the market. Moreover, emerging companies struggle to leverage cash flow as the production of DCDPS comes with high production costs. Thus, the adoption of forward integration by leading manufacturers to produce polysulfones and Dapsone could create a DCDPS deficit in the market.

Country-wise Insights

India Expected to be a Massive Opportunity Ground DCDPS Suppliers

India accounts for a lion’s share in the 4,4-dichlorodiphenyl sulfone market and is projected to account for 92% revenue share of the South Asia & Oceania market. India is becoming a hub for the production of most specialty chemicals, gaining a lot of support from the government as well as foreign investors.

Given the strengthening economy of the country, India is becoming a self-reliant country with the least dependency on neighboring countries. Another reason for the growth of the DCDPS market is the building up of a strong base for medical infrastructure to successfully combat issues such as the global pandemic.

The DCDPS market in India is projected to grow at a CAGR of 5% over the forecast period.

China’s Expanding Utilization of DCDPS to Overpower U.S. Market Growth

The 4,4-dichlorodiphenyl sulfone market in the Americas was valued at US$ 63.3 million in 2021 and is expected to expand at a CAGR of 3.3% by 2032. The market in East Asia was valued at US$ 97.2 million in 2021 and is expected to expand at a CAGR of 3.9% through 2032.

China will lead the regional market in terms of consumption. China’s excellent performance is mainly due to its strong economy and the availability of abundant raw materials and cheap labor.

Though China is experiencing an economic slowdown post-pandemic and disturbing relations with the U.S., market growth is expected to escalate during the forecast period.

Category-wise Insights

Increasing Investments in Healthcare Infrastructure to Drive Demand for Pharma Grade DCDPS

4,4-dichlorodiphenyl sulfone is used for the production of polysulfone monomers. These are further utilized in dialyzer membranes and other filtration membranes used in critical medical procedures. These membranes have optimal permeability and are specific for favorable clinical outcomes.

Also, the need to strengthen medical infrastructure has tremendously elevated the demand for pharma grade 4,4-dichlorodiphenyl sulfone. The segment is expected to progress at 5.3% CAGR through 2032.

Demand for DCDPS Redirected towards Polyethersulfone (PES)

PES is a highly preferred material under engineered plastics for the production of industrial process equipment. These are mainly used for manufacturing valves and pumps in electrochemical industries. In addition, these are used in distillation columns, automatic beverage filling dispensers, conveyor belts, etc.

Conventionally, the use of PES was not defined, but owing to technological innovations and upgradation in the industrial sector, the growth rate of PES has heightened from 2.1% (2017 to 2021) to an expected 4.2% CAGR (2022 to 2032).

Competition Analysis

Prominent 4,4-dichlorodiphenyl sulfone manufacturers are Solvay S.A., Aarti Industries Limited, Atul Limited, Vertellus Holdings LLC., Hebei Xulong Chemical Co. Ltd., Jiujiang Zhongxing Medicine Chemical Co. Ltd, Tci Chemicals (India) Private Limited, and Banchem Intermediates (India) Private Limited.

Leading producers of 4,4-dichlorodiphenyl sulfone products are employing methodologies for the captive consumption of DCDPS for their sulfone production units. Key suppliers are also focused on increasing their production capacity to meet the increasing demand. Moreover, manufacturers are collaborating to provide sustainable solutions and reduce plastic waste generated after degradation.

• Solvay & Mitsubishi Chemical have collaborated to recycle polysulfone thermoplastics with the goal of material reusing instead of it being disposed into landfills.
• In 2022, Solvay S.A announced the expansion of its U.S.-based sulfone business through capacity expansion and upstream integration to meet the increasing demand from the life sciences sector.

Fact.MR has provided detailed information about the price points of key manufacturers of 4,4-dichlorodiphenyl sulfone positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.

Segmentation of 4,4-Dichlorodiphenyl Sulfone Industry Survey

• By Grade :

  • Industrial Grade
  • Pharma Grade
  • Reagent Grade

• By Application :

  • Engineered Plastics
    • Polysulfone (PSU)
    • Polyethersulfone (PESU)
    • PolyPhenylSulfone (PPSU)
  • Pharmaceuticals
  • Others

• By Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • MEA